Myconostica is proud to report that Professor David Denning, Founder and Chief Medical Officer of Myconostica was elected as a Fellow of the Academy of Medical Sciences on June 22^nd 2010.  The Academy of Medical Sciences is a prestigious body within the UK medical community established to promote advances in medical science and campaigns to ensure these are translated into healthcare benefits for society.

For further information please contact:

Myconostica Ltd
Heidi Wahlefeld-Moghimi
Heidi.Wahlefeld@myconostica.co.uk
+44 (0)161 998 7239

Media Enquiries:
Cardew Group
Tim Robertson
+44 (0)20 7930 0777

About Myconostica Ltd.

Myconostica Ltd, a UK-based medical diagnostic company, specialises in rapid and highly specific tests for life-threatening fungal infections. Traditional methods of the detection of fungal infections are well documented as being relatively insensitive and slow.  Tests provided by Myconostica aim to allow healthcare professionals to rapidly identify patients infected thus enabling clinicians to prescribe appropriate drug therapy.
Myconostica is developing and commercialising a portfolio of real-time molecular diagnostic tests for life-threatening fungal infections. Over 10 million people are at risk of these infections each year in Europe and North America alone.
 
On the web: www.myconostica.co.uk